3 reasons why biotechs preparing for launch need a compliant content foundation
Industry data estimates that by 2026, first-time biotech launches will outnumber those from established companies by more than two to…
Macro
-
-
Mastering compliance and copyright in healthcare and MedComms
In a recent webinar, Marc McArdle, CLA Customer Success Manager, was joined by Jackie Marchington, Head of Compliance and Ethics…
-
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
The biosciences and healthcare industries are evolving rapidly, demanding innovative solutions and skilled professionals. Professor Vikki Rand, Director of Teesside…
-
GSK stays optimistic on vaccines amidst US and China woes
GSK blames political and regulatory pressures for the decline in its vaccine’s business in 2024, as it expects sales to…
-
Shionogi awarded $375m from HHS for preventative Covid-19 injectable
Shionogi has been awarded $375m by the US Department of Health and Human Services (HHS) to develop a long-acting therapeutic…
-
JP Morgan 2025: Incyte expects period of ‘defining catalysts’
Incyte CEO Hervé Hoppenot has promised investors that 2025 will be “a year that will be full of many defining…
-
FDA CDER director Patrizia Cavazzoni announces resignation
The US Food and Drugs Administration (FDA) has confirmed that its director of the Centre for Drug Evaluation and Research…
-
Alzheimer’s total prevalent cases to reach 22.51 million in 8MM in 2033
Estimates by data analytics company GlobalData suggest that the total prevalent cases of Alzheimer’s disease (according to the DSM-IV criteria)…
-
Eli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst
Eli Lilly’s recently-announced investment into the UK’s life sciences sector “marks a pivotal moment for the industry”, according to GlobalData’s…
-
Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
Petrovax has announced encouraging findings from the Long-CoV-III-21 trial, a randomised, double-blind, placebo-controlled study evaluating the efficacy and safety of…
